EASD 2021: Osteoporosis drug appears to lower diabetes risk
Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the… read more.
Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the… read more.
Chronic back pain affects upwards of 15 million adults in the US, racking up billions in healthcare costs and lost work days. Degeneration of the discs that cushion… read more.
Prosthetic enables a wide range of daily activities, such as zipping a suitcase, shaking hands, and petting a cat. Massachusetts Institute of Technology An MIT-developed inflatable robotic hand… read more.
New research carried out under the auspices of the Canadian Multicentre Osteoporosis Study (CaMos) has found that cognitive decline is linked with accelerated bone loss and an increased… read more.
Bristol Myers Squibb Canada announced Health Canada has granted conditional approval (NOC/c) for Abecma (idecabtagene vicleucel; ide-cel) as the first and only B-cell maturation antigen (BCMA)-directed chimeric antigen… read more.
A new study from Columbia University and an international team of researchers identifies multiple ways to achieve the same health benefits from exercise — as long as the… read more.
Genentech, announced new 2-year data from Part 2 of FIREFISH, a Phase II/III global study evaluating Evrysdi (risdiplam) in infants aged 1-7 months at enrollment with symptomatic Type… read more.
Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of once-weekly… read more.
Article written by Bruce Sylvester Antidepressants do not appear to provide significant back or osteoarthritis pain relief, even though they are widely prescribed for such purposes, researchers reported… read more.
by Bruce Sylvester: Postmenopausal women with osteoporosis who have received daily treatment with the investigative drug abaloparatide achieved a significantly reduced the risk of new vertebral and non-vertebral… read more.
by Gary Finnegan: Rapid weight loss can lead to a loss of bone mass and an increased risk of bone fractures. A study by University of Copenhagen, Hvidovre… read more.
While the consequences of osteoporosis are worse in men than women – including death – older males are far less likely to take preventive measures against the potentially… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.